Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

European journal of clinical investigation
Published

Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke

Authors
Andrea Morotti, Mathias Sauer, Francesco Berinato, Marcello Catania, Andrea L Benedet, Chiara Tolassi, Guglielmo Di Molfetta, Ilaria Pola, Henrik Zetterberg, Nicholas J Ashton, Andrea Pilotto, Alessandro Padovani
Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke
Acta neuropathologica communications
Published

Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer's disease

Authors
Carlos Avilés-Granados, Adriana Gea-González, Jorge Sáez-Leyva, Sylvia E Perez, Elliott J Mufson, Ann-Charlotte Granholm, María Carmona-Iragui, Henrik Zetterberg, Kaj Blennow, Juan Fortea, María-Salud García-Ayllón, Javier Sáez-Valero
Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer's disease
NPJ Parkinson's disease
Published

Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease

Authors
Alena M Smith, Sara A Lorkiewicz, Burak Arslan, Laia Montoliu-Gaya, Nicholas J Ashton, Edward N Wilson, Daniel Alcolea, Íñigo Rodríguez-Baz, Juan Fortea, Christina B Young, Joseph R Winer, Marian Shahid-Besanti, Hillary Vossler, Melanie J Plastini, Tianyu Pan, Elena Vera-Campuzano, Isabel Sala, Justin H Mendiola, Veronica Ramirez, Geoffrey A Kerchner, Katrin I Andreasson, Victor W Henderson, Thomas J Montine, Lu Tian, Elizabeth C Mormino, Henrik Zetterberg, Kathleen L Poston, Carla Abdelnour
Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab